SGLT2 inhibitor therapy is a treatment option for people with type 2 diabetes, heart failure, and chronic kidney disease. These medicines help the kidneys remove excess glucose through urine, supporting blood sugar management while offering heart and kidney benefits.
How SGLT2 Inhibitors Work
SGLT2 inhibitors reduce glucose and sodium reabsorption in the kidneys, allowing more glucose to leave the body through urine. Depending on the medicine and patient profile, treatment may improve glycemic control and reduce certain heart failure or kidney-related risks.
Who May Benefit?
A diabetologist or endocrinologist may consider SGLT2 inhibitor treatment for people with type 2 diabetes, especially when cardiovascular or kidney health is a concern. The choice depends on kidney function, conditions, other medicines, and goals.
Benefits and Safety
Potential benefits include blood sugar management and, in appropriate patients, reduced risk of heart failure hospitalization and progression of chronic kidney disease. Possible side effects include increased urination, dehydration, low blood pressure, and genital or urinary infections. Rare but serious complications such as diabetic ketoacidosis can occur, making supervision important.
Before Starting Treatment
Your doctor may review blood glucose, kidney function, hydration, medicines, and other health conditions before prescribing an SGLT2 inhibitor. Never start, stop, or change the dose without medical advice.